Skip to main content
. 2020 Sep 25;7(6):3841–3850. doi: 10.1002/ehf2.12974

FIGURE 2.

FIGURE 2

Data of the comparative analysis for the effective outcomes of all‐cause mortality and cardiovascular mortality in different patients with HF. HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; Sac/Val, sacubitril‐valsartan.